Skip to main content
Erschienen in: Annals of Hematology 10/2022

03.08.2022 | Original Article

Prognostic value and computer image analysis of p53 in mantle cell lymphoma

verfasst von: Yue-Hua Zhang, Li-Min Gao, Xiao-Yu Xiang, Wen-Yan Zhang, Wei-Ping Liu

Erschienen in: Annals of Hematology | Ausgabe 10/2022

Einloggen, um Zugang zu erhalten

Abstract

P53 prognostic cut-off values differ between studies of mantle cell lymphoma (MCL), and its immunohistochemistry (IHC) interpretation is still based on semiquantitative estimation, which might be inaccurate. This study aimed to investigate the optimal cut-off value for p53 in predicting prognosis of patients with MCL and the possible use of computer image analysis to identify the positive rate of p53. We calculated p53 positive rate using QuPath software and compared it with the data obtained by manual counting and semiquantitative estimation. Survival curves were generated by using the Youden index and the Kaplan–Meier method. The chi-squared (χ2) test was used to compare MIPI, Ann Arbor stage, and cell morphology with p53. Spearman rank correlation test and Bland–Altman analysis were used to compare manual counting, computer image analysis and semiquantitative estimation, as well as the consistency between different observers. The optimal cut-off value of p53 for predicting prognosis was 20% in MCL patients. Patients with p53 ≥ 20% had a significantly worse overall survival (OS) than those with p53 < 20% (P < 0.0001). MCL patients with MIPI intermediate to high risk, Ann Arbor stage III–IV, and blastoid/pleomorphic variant cell morphology had more p53 ≥ 20%. There was a strong correlation between computer image analysis and manual counting of p53 from the same areas in MCL tissues (Spearman’s rho = 0.966, P < 0.0001). The results of computer analysis are completely consistent between observers, and computer image analysis of Ki-67 can predict the prognosis of MCL patients. MCL patients with p53 ≥ 20% had a shorter OS and a tendency for MIPI intermediate to high risk, Ann Arbor stage III–IV, and blastoid/pleomorphic variant. Computer image analysis could determine the actual positive rate of p53 and Ki-67 and is a more attractive alternative than semiquantitative estimation in MCL.

Graphical abstract

Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Hermine O, Hoster E, Walewski J, Bosly A, Stilgenbauer S, Thieblemont C, Szymczyk M, Bouabdallah R, Kneba M, Hallek M, Salles G, Feugier P, Ribrag V, Birkmann J, Forstpointner R, Haioun C, Hänel M, Casasnovas RO, Finke J, Peter N, Bouabdallah K, Sebban C, Fischer T, Dührsen U, Metzner B, Maschmeyer G, Kanz L, Schmidt C, Delarue R, Brousse N, Klapper W, Macintyre E, Delfau-Larue MH, Pott C, Hiddemann W, Unterhalt M, Dreyling M (2016) Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network. Lancet (London, England) 388(10044):565–575. https://doi.org/10.1016/s0140-6736(16)00739-xCrossRef Hermine O, Hoster E, Walewski J, Bosly A, Stilgenbauer S, Thieblemont C, Szymczyk M, Bouabdallah R, Kneba M, Hallek M, Salles G, Feugier P, Ribrag V, Birkmann J, Forstpointner R, Haioun C, Hänel M, Casasnovas RO, Finke J, Peter N, Bouabdallah K, Sebban C, Fischer T, Dührsen U, Metzner B, Maschmeyer G, Kanz L, Schmidt C, Delarue R, Brousse N, Klapper W, Macintyre E, Delfau-Larue MH, Pott C, Hiddemann W, Unterhalt M, Dreyling M (2016) Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network. Lancet (London, England) 388(10044):565–575. https://​doi.​org/​10.​1016/​s0140-6736(16)00739-xCrossRef
3.
Zurück zum Zitat X-q LI, G-d LI, Z-f GAO, X-g ZHOU, X-z ZHU (2012) Distribution pattern of lymphoma subtypes in China: a nationwide multicenter study of 10002 cases. Journal of Diagnostics Concepts & Practice 11(02):111–115 X-q LI, G-d LI, Z-f GAO, X-g ZHOU, X-z ZHU (2012) Distribution pattern of lymphoma subtypes in China: a nationwide multicenter study of 10002 cases. Journal of Diagnostics Concepts & Practice 11(02):111–115
4.
Zurück zum Zitat Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, Pfreundschuh M, Reiser M, Metzner B, Einsele H, Peter N, Jung W, Wörmann B, Ludwig WD, Dührsen U, Eimermacher H, Wandt H, Hasford J, Hiddemann W, Unterhalt M (2008) A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 111(2):558–565. https://doi.org/10.1182/blood-2007-06-095331CrossRefPubMed Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, Pfreundschuh M, Reiser M, Metzner B, Einsele H, Peter N, Jung W, Wörmann B, Ludwig WD, Dührsen U, Eimermacher H, Wandt H, Hasford J, Hiddemann W, Unterhalt M (2008) A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 111(2):558–565. https://​doi.​org/​10.​1182/​blood-2007-06-095331CrossRefPubMed
5.
Zurück zum Zitat Hoster E, Rosenwald A, Berger F, Bernd HW, Hartmann S, Loddenkemper C, Barth TF, Brousse N, Pileri S, Rymkiewicz G, Kodet R, Stilgenbauer S, Forstpointner R, Thieblemont C, Hallek M, Coiffier B, Vehling-Kaiser U, Bouabdallah R, Kanz L, Pfreundschuh M, Schmidt C, Ribrag V, Hiddemann W, Unterhalt M, Kluin-Nelemans JC, Hermine O, Dreyling MH, Klapper W (2016) Prognostic value of Ki-67 Index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the European Mantle Cell Lymphoma Network. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 34(12):1386–1394. https://doi.org/10.1200/jco.2015.63.8387CrossRef Hoster E, Rosenwald A, Berger F, Bernd HW, Hartmann S, Loddenkemper C, Barth TF, Brousse N, Pileri S, Rymkiewicz G, Kodet R, Stilgenbauer S, Forstpointner R, Thieblemont C, Hallek M, Coiffier B, Vehling-Kaiser U, Bouabdallah R, Kanz L, Pfreundschuh M, Schmidt C, Ribrag V, Hiddemann W, Unterhalt M, Kluin-Nelemans JC, Hermine O, Dreyling MH, Klapper W (2016) Prognostic value of Ki-67 Index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the European Mantle Cell Lymphoma Network. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 34(12):1386–1394. https://​doi.​org/​10.​1200/​jco.​2015.​63.​8387CrossRef
6.
Zurück zum Zitat Dreyling M, Campo E, Hermine O, Jerkeman M, Le Gouill S, Rule S, Shpilberg O, Walewski J, Ladetto M (2017) Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology 28 (suppl_4):iv62-iv71. https://doi.org/10.1093/annonc/mdx223 Dreyling M, Campo E, Hermine O, Jerkeman M, Le Gouill S, Rule S, Shpilberg O, Walewski J, Ladetto M (2017) Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology 28 (suppl_4):iv62-iv71. https://​doi.​org/​10.​1093/​annonc/​mdx223
10.
Zurück zum Zitat Aukema SM, Hoster E, Rosenwald A, Canoni D, Delfau-Larue MH, Rymkiewicz G, Thorns C, Hartmann S, Kluin-Nelemans H, Hermine O, Dreyling M, Klapper W (2018) Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network. Blood 131(4):417–420. https://doi.org/10.1182/blood-2017-07-797019CrossRefPubMed Aukema SM, Hoster E, Rosenwald A, Canoni D, Delfau-Larue MH, Rymkiewicz G, Thorns C, Hartmann S, Kluin-Nelemans H, Hermine O, Dreyling M, Klapper W (2018) Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network. Blood 131(4):417–420. https://​doi.​org/​10.​1182/​blood-2017-07-797019CrossRefPubMed
11.
Zurück zum Zitat Nordström L, Sernbo S, Eden P, Grønbaek K, Kolstad A, Räty R, Karjalainen ML, Geisler C, Ralfkiaer E, Sundström C, Laurell A, Delabie J, Ehinger M, Jerkeman M, Ek S (2014) SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma–a Nordic Lymphoma Group study. Br J Haematol 166(1):98–108. https://doi.org/10.1111/bjh.12854CrossRefPubMedPubMedCentral Nordström L, Sernbo S, Eden P, Grønbaek K, Kolstad A, Räty R, Karjalainen ML, Geisler C, Ralfkiaer E, Sundström C, Laurell A, Delabie J, Ehinger M, Jerkeman M, Ek S (2014) SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma–a Nordic Lymphoma Group study. Br J Haematol 166(1):98–108. https://​doi.​org/​10.​1111/​bjh.​12854CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Choe JY, Yun JY, Na HY, Huh J, Shin SJ, Kim HJ, Paik JH, Kim YA, Nam SJ, Jeon YK, Park G, Kim JE (2016) MYC overexpression correlates with MYC amplification or translocation, and is associated with poor prognosis in mantle cell lymphoma. Histopathology 68(3):442–449. https://doi.org/10.1111/his.12760CrossRefPubMed Choe JY, Yun JY, Na HY, Huh J, Shin SJ, Kim HJ, Paik JH, Kim YA, Nam SJ, Jeon YK, Park G, Kim JE (2016) MYC overexpression correlates with MYC amplification or translocation, and is associated with poor prognosis in mantle cell lymphoma. Histopathology 68(3):442–449. https://​doi.​org/​10.​1111/​his.​12760CrossRefPubMed
13.
Zurück zum Zitat Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA (2017) WHO classification of tumors of haematopoietic and lymphoid tissues. Revised 4th Edition. IARC press, Lyon, France Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA (2017) WHO classification of tumors of haematopoietic and lymphoid tissues. Revised 4th Edition. IARC press, Lyon, France
14.
Zurück zum Zitat Kämmerer U, Kapp M, Gassel AM, Richter T, Tank C, Dietl J, Ruck P (2001) A new rapid immunohistochemical staining technique using the EnVision antibody complex. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 49(5):623–630. https://doi.org/10.1177/002215540104900509CrossRef Kämmerer U, Kapp M, Gassel AM, Richter T, Tank C, Dietl J, Ruck P (2001) A new rapid immunohistochemical staining technique using the EnVision antibody complex. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 49(5):623–630. https://​doi.​org/​10.​1177/​0022155401049005​09CrossRef
16.
Zurück zum Zitat Paulik R, Micsik T, Kiszler G, Kaszál P, Székely J, Paulik N, Várhalmi E, Prémusz V, Krenács T, Molnár B (2017) An optimized image analysis algorithm for detecting nuclear signals in digital whole slides for histopathology. Cytometry Part A : the journal of the International Society for Analytical Cytology 91(6):595–608. https://doi.org/10.1002/cyto.a.23124CrossRef Paulik R, Micsik T, Kiszler G, Kaszál P, Székely J, Paulik N, Várhalmi E, Prémusz V, Krenács T, Molnár B (2017) An optimized image analysis algorithm for detecting nuclear signals in digital whole slides for histopathology. Cytometry Part A : the journal of the International Society for Analytical Cytology 91(6):595–608. https://​doi.​org/​10.​1002/​cyto.​a.​23124CrossRef
17.
Zurück zum Zitat DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837–845CrossRef DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837–845CrossRef
19.
Zurück zum Zitat Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (London, England) 1(8476):307–310CrossRef Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (London, England) 1(8476):307–310CrossRef
20.
Zurück zum Zitat Zelenetz AD, Gordon LI, Chang JE, Christian B, Abramson JS, Advani RH, Bartlett NL, Budde LE, Caimi PF, De Vos S, Dholaria B, Fakhri B, Fayad LE, Glenn MJ, Habermann TM, Hernandez-Ilizaliturri F, Hsi E, Hu B, Kaminski MS, Kelsey CR, Khan N, Krivacic S, LaCasce AS, Lim M, Narkhede M, Rabinovitch R, Ramakrishnan P, Reid E, Roberts KB, Saeed H, Smith SD, Svoboda J, Swinnen LJ, Tuscano J, Vose JM, Dwyer MA, Sundar H (2021) NCCN Guidelines® insights: b-cell lymphomas, Version 5.2021. Journal of the National Comprehensive Cancer Network : JNCCN 19 (11):1218–1230. https://doi.org/10.6004/jnccn.2021.0054 Zelenetz AD, Gordon LI, Chang JE, Christian B, Abramson JS, Advani RH, Bartlett NL, Budde LE, Caimi PF, De Vos S, Dholaria B, Fakhri B, Fayad LE, Glenn MJ, Habermann TM, Hernandez-Ilizaliturri F, Hsi E, Hu B, Kaminski MS, Kelsey CR, Khan N, Krivacic S, LaCasce AS, Lim M, Narkhede M, Rabinovitch R, Ramakrishnan P, Reid E, Roberts KB, Saeed H, Smith SD, Svoboda J, Swinnen LJ, Tuscano J, Vose JM, Dwyer MA, Sundar H (2021) NCCN Guidelines® insights: b-cell lymphomas, Version 5.2021. Journal of the National Comprehensive Cancer Network : JNCCN 19 (11):1218–1230. https://​doi.​org/​10.​6004/​jnccn.​2021.​0054
22.
Zurück zum Zitat Abrisqueta P, Scott DW, Slack GW, Steidl C, Mottok A, Gascoyne RD, Connors JM, Sehn LH, Savage KJ, Gerrie AS, Villa D (2017) Observation as the initial management strategy in patients with mantle cell lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology 28(10):2489–2495. https://doi.org/10.1093/annonc/mdx333CrossRef Abrisqueta P, Scott DW, Slack GW, Steidl C, Mottok A, Gascoyne RD, Connors JM, Sehn LH, Savage KJ, Gerrie AS, Villa D (2017) Observation as the initial management strategy in patients with mantle cell lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology 28(10):2489–2495. https://​doi.​org/​10.​1093/​annonc/​mdx333CrossRef
23.
Zurück zum Zitat Kimura Y, Sato K, Arakawa F, Karube K, Nomura Y, Shimizu K, Aoki R, Hashikawa K, Yoshida S, Kiyasu J, Takeuchi M, Nino D, Sugita Y, Morito T, Yoshino T, Nakamura S, Kikuchi M, Ohshima K (2010) Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67. Cancer Sci 101(3):806–814. https://doi.org/10.1111/j.1349-7006.2009.01433.xCrossRefPubMed Kimura Y, Sato K, Arakawa F, Karube K, Nomura Y, Shimizu K, Aoki R, Hashikawa K, Yoshida S, Kiyasu J, Takeuchi M, Nino D, Sugita Y, Morito T, Yoshino T, Nakamura S, Kikuchi M, Ohshima K (2010) Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67. Cancer Sci 101(3):806–814. https://​doi.​org/​10.​1111/​j.​1349-7006.​2009.​01433.​xCrossRefPubMed
Metadaten
Titel
Prognostic value and computer image analysis of p53 in mantle cell lymphoma
verfasst von
Yue-Hua Zhang
Li-Min Gao
Xiao-Yu Xiang
Wen-Yan Zhang
Wei-Ping Liu
Publikationsdatum
03.08.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Annals of Hematology / Ausgabe 10/2022
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-022-04922-8

Weitere Artikel der Ausgabe 10/2022

Annals of Hematology 10/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.